Facebook
Twitter
LinkedIn
ForwardSubstance Use Disorders Management Boot Camp (September 19-20, 2024)
Date
September 19-20, 2024
Activity Format
Live In-Person
Overview
This training aims to enhance confidence and competencies related to the management of substance use disorders in general medical settings. Through case-based and interactive didactic content, the workshop will explore issues related to assessment, monitoring, prevention, and management of issues that commonly occur with substance use (for example addiction, infectious disease, mental health issues.
Intended Audience
This program is designed for physicians, advanced practice nurses, and nurses who treat patients with opioid use disorder.
Learning Objectives
As a result of participating in this activity, learners, as members of the healthcare team, will be able to:
- Determine accurate diagnosis and initiate treatment for opioid use disorder, alcohol withdrawal, and alcohol use disorder
- Demonstrate skills needed to work with patients who continue to use drugs and alcohol while in treatment for use disorder
- Determine appropriate treatment plan for OUD and AUD, including the initiation and maintenance of buprenorphine therapy, alcohol withdrawal management, and MAUD.
- Develop approaches to working with and managing patients with stimulant use disorders.
- Determine appropriate approach to evaluation and management of Hepatitis C.
Elements of Competence
This educational activity is designed to change learner competence and focuses on the following competencies:
- Accreditation Council for Graduate Medical Education (ACGME)/Nursing: Patient Care & Procedural Skills, Medical Knowledge, Interpersonal & Communication Skills, and Professionalism
- National Academy of Medicine (NAM)/Nursing: Provide patient/person-centered care, Employ evidence-based practice, and Population Health
- Interprofessional Education Collaborative Competencies: Values/ethics for interprofessional practice, Roles & Responsibilities, and Teams & Teamwork
- UW ICEP Diversity, Equity, and Inclusion: Engage in Self-reflection, Address Health Disparities, and Value Diversity in the Clinical Encounter.
All times listed are in Central Daylight Time (CDT)
| Thursday, September 19 | |
|---|---|
| 08:00 am- 9:00 am | Breakfast/ Welcome |
| 9:00 am - 9:30 am | Introductions/ Opioid Use and Related Trends: Dr. Randy Brown |
| 9:30 am - 10:30 am | Inductionology: The Art of Buprenorphine Induction in the Age of Fentanyl (Drs. Alison Miller/ Jillian Landeck) |
| 10:30 am - 11:00 am | Case Discussion |
| 11:00 am - 11:15 am | Break |
| 11:15 am - 11:45 am | Extended-Release Buprenorphine Products (Dr. David Leinweber) |
| 11:45 am - 12:00 pm | Group Q and A |
| 12:00 pm - 12:45 pm | Lunch |
| 12:45 pm - 1:30 pm | Stimulant Use Disorder (Dr. Leinweber) |
| 1:30 pm - 2:00 pm | Case Discussion |
| 2:00 pm - 2:15 pm | Break |
| 2:15 pm - 3:00 pm | Harm Reduction Services |
| 3:00 - 3:45 pm | Chronic Pain (Dr. Randy Brown) |
| 3:45 - 4:00 pm | Group Q and A |
| Friday, September 20 | |
| 8:00 am - 8:30 am | Breakfast |
| 8:30 am - 9:15 am | Alcohol Use Disorder (Dr. Brown) |
| 9:15 am - 9:45 am | Case Discussion |
| 9:45 am - 10:00 am | Break |
| 10:00 am - 10:45 am | Motivational Interviewing |
| 10:45 am - 11:30 am | Hep C (Dr. Landeck) |
| 11:30 am - 12:00 pm | Lunch |
| 12:00 pm - 12:45 pm | Peer Support and Recovery |
| 12:45 pm - 1:15 pm | Wrap up/ Resources |
To book lodging at Stone Harbor Resort with special conference rate, please contact the resort and reference the “Substance Use Disorders Management Boot Camp”. Discounted rates will be available until August 18th, 2024.
For additional questions, please contact Kathleen Maher, kathleen.maher@fammed.wisc.edu.
Learners are responsible for their own transportation and lodging.
Planners/Presenters
- Randy Brown, MD, PhD, DFASAM
- Jillian Landeck, MD
- David Leinweber, MD
- Alison Miller, MD
- Kendelle Nelson
- Ben Bruso
- Julia Yates, LCSW
- Kathleen Maher, Lead Outreach Specialist
- Jill Lindwall, MSN, RN, CPHQ
- Megan Ringo
- Maggie Williams, Williams, PA
- Kelly Eagen
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Randy Brown, MD, PhD, DFASAM | Course Director | No relevant relationships with ineligible companies to disclose | Yes |
Kelly Eagen, MD | Planner | No relevant relationships with ineligible companies to disclose | No |
Jillian Landeck, MD | Planner | No relevant relationships with ineligible companies to disclose | No |
David Leinweber, MD | Planner | No relevant relationships with ineligible companies to disclose | Yes |
Jill Lindwall, RN | Planner | No relevant relationships with ineligible companies to disclose | No |
Alison Miller, MD | Planner | No relevant relationships with ineligible companies to disclose | No |
Amy Parins | Planner | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
| American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 9.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 9.25 ANCC contact hours, 5.25 of which are eligible for pharmacotherapeutic contact hours. |
 | American Academy of Physician Assistants (AAPA) The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |
| Wisconsin Medical Examining Board Opioid CME This course is approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code. Course Title: Substance Use Disorders Management Boot Camp (September 19-20, 2024) Medication Access and Training Expansion (MATE) Act This course is designed to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act. (Click here for more information.) Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.925 CEUs or 9.25 hours. |
Available Credit
- 9.25 AAPA Category 1 CME
- 9.25 Wisconsin Responsible Opioid Prescribing Credit
- 9.25 AMA PRA Category 1 Credit™
- 9.25 Wisconsin Responsible Opioid Prescribing Credit
- 9.25 ANCC Contact Hours
- 9.25 Wisconsin Responsible Opioid Prescribing Credit
- 9.25 University of Wisconsin–Madison Continuing Education Hours
- 9.25 Approved for AMA PRA Category 1 Credit™
- 9.25 Wisconsin Responsible Opioid Prescribing Credit
Click Begin, then complete your registration by answering the questions in step 1 of the Course Progress bar
This activity is in-person only.
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to help@icep.wisc.edu.
Questions about event and venue
Email Kathleen Maher kathleen.maher@fammed.wisc.edu
Questions about registration
Email help@icep.wisc.edu.
Program changes
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Accessibility
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu
For further information
For additional questions about the conference, including accessibility requests, please contact: Kathleen Maher kathleen.maher@fammed.wisc.edu.